Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Operating Expenses | 14,393 | 4,027 | 3,968 | 4,048 | 3,338 |
| Operating Income | -14,393 | -4,027 | -3,968 | -4,048 | -3,338 |
| Interest Expense | 77 | 13 | 0 | 0 | 0 |
| Other Income | 17 | 27 | 43 | 83 | 128 |
| Pre-tax Income | -14,454 | -4,013 | -3,925 | -3,964 | -3,210 |
| Net Income Continuous | -14,454 | -4,013 | -3,925 | -3,964 | -3,210 |
| Net Income | $-14,454 | $-4,013 | $-3,925 | $-3,964 | $-3,210 |
| EPS Basic Total Ops | -4,350.00 | -1,200.00 | -1,200.00 | -1,200.00 | -650.00 |
| EPS Basic Continuous Ops | -4,370.22 | -1,214.21 | -1,188.72 | -1,201.20 | -820.30 |
| EPS Diluted Total Ops | -4,350.00 | -1,200.00 | -1,200.00 | -1,200.00 | -650.00 |
| EPS Diluted Continuous Ops | -4,370.22 | -1,214.21 | -1,188.72 | -1,201.20 | -820.30 |
| EBITDA(a) | $-14,357 | $-3,982 | $-3,921 | $-3,995 | $-3,282 |